IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 34,726,651
- Share change
- +1,824,891
- Total reported value
- $820,669,496
- Price per share
- $23.64
- Number of holders
- 108
- Value change
- +$42,947,568
- Number of buys
- 70
- Number of sells
- 30
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
3.7%
|
3,266,255
|
$83,257,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.4%
|
3,011,666
|
$76,766,000 | — | 30 Sep 2021 | |
| Canaan Partners X LLC |
13F
|
Company |
3%
|
2,660,713
|
$67,821,000 | — | 30 Sep 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
2.8%
|
2,437,000
|
$62,119,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.7%
|
2,335,906
|
$59,542,000 | — | 30 Sep 2021 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.6%
|
2,305,176
|
$58,759,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
2.5%
|
2,202,812
|
$56,150,000 | — | 30 Sep 2021 | |
| Logos Global Management LP |
13F
|
Company |
2%
|
1,775,000
|
$45,245,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
1,415,948
|
$36,092,000 | — | 30 Sep 2021 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.6%
|
1,398,066
|
$35,637,000 | — | 30 Sep 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
1.3%
|
1,151,998
|
$29,364,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
1,039,701
|
$26,502,000 | — | 30 Sep 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.1%
|
983,200
|
$25,062,000 | — | 30 Sep 2021 | |
| Alphabet Inc. |
13F
|
Company |
0.86%
|
753,187
|
$19,199,000 | — | 30 Sep 2021 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.66%
|
575,940
|
$14,681,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
530,767
|
$13,529,000 | — | 30 Sep 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.52%
|
460,061
|
$11,727,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
0.41%
|
361,004
|
$9,203,000 | — | 30 Sep 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.39%
|
339,180
|
$8,644,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.35%
|
308,744
|
$7,870,000 | — | 30 Sep 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.34%
|
294,619
|
$7,510,000 | — | 30 Sep 2021 | |
| AXA S.A. |
13F
|
Company |
0.32%
|
278,733
|
$7,105,000 | — | 30 Sep 2021 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.31%
|
267,990
|
$6,835,000 | — | 30 Sep 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.28%
|
250,000
|
$6,373,000 | — | 30 Sep 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.28%
|
242,182
|
$6,173,000 | — | 30 Sep 2021 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
173,500
|
$4,423,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.16%
|
144,379
|
$3,680,000 | — | 30 Sep 2021 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.16%
|
139,950
|
$3,566,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.14%
|
124,863
|
$3,353,000 | — | 30 Sep 2021 | |
| Michael P. Dillon |
3/4/5
|
SVP, Chief Scientific Officer |
—
mixed-class rows
|
102,226
mixed-class rows
|
$3,311,116 | — | 04 Oct 2021 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.14%
|
118,619
|
$3,023,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
110,422
|
$2,815,000 | — | 30 Sep 2021 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.12%
|
109,000
|
$2,778,000 | — | 30 Sep 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.1%
|
91,690
|
$2,337,000 | — | 30 Sep 2021 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.1%
|
90,199
|
$2,299,000 | — | 30 Sep 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.1%
|
85,930
|
$2,190,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
83,185
|
$2,121,000 | — | 30 Sep 2021 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
66,602
|
$1,698,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
55,884
|
$1,424,000 | — | 30 Sep 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.06%
|
56,309
|
$1,416,000 | — | 30 Sep 2021 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.06%
|
54,575
|
$1,391,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.06%
|
52,700
|
$1,343,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
44,371
|
$1,131,000 | — | 30 Sep 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.04%
|
36,915
|
$941,000 | — | 30 Sep 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
35,260
|
$899,000 | — | 30 Sep 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.04%
|
31,475
|
$802,000 | — | 30 Sep 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
29,600
|
$755,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
27,383
|
$698,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.03%
|
25,224
|
$643,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
24,782
|
$632,000 | — | 30 Sep 2021 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q4 2021
As of 31 Dec 2021,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,726,651 shares.
The largest 10 holders included
BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Canaan Partners X LLC, Avidity Partners Management LP, RTW INVESTMENTS, LP, FEDERATED HERMES, INC., BOXER CAPITAL, LLC, STATE STREET CORP, Logos Global Management LP, and VANGUARD GROUP INC.
This page lists
108
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
90
Q4 2021 holders
108
Holder diff
18
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.